MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin beta 1 pathway

Objective. Mucin (MIX) 20 has recently been implicated to play a role in human carcinogenesis. However, the role of MUC20 in epithelial ovarian cancer (EOC) remains to be elucidated. Methods. MUC20 expression was assessed in tissue microarray and tumor specimens of EOC patients by immunohistochemistry. Effects of MUC20 on cell viability, adhesion, migration, and invasion were analyzed in MUC20 overexpressing or knockdown EOC cells. Western blotting was performed to analyze signaling pathways modulated by MUC20. Results. MUC20 was overexpressed in EOC samples compared with benign tissues. High MUC20 expression was significantly associated with poor overall survival in patients with advanced-stage disease. MUC20 overexpression significantly enhanced EOC cell migration and invasion, but not viability. Mechanistic investigations showed that MUC20 increased cell adhesion to extracellular matrix (ECM) proteins and enhanced activation of integrin beta 1 and phosphorylation of focal adhesion kinase (FAK). The enhancement of cell motility and the integrin beta 1 signaling by MUC20 was significantly suppressed by integrin beta 1 blocking antibody. Furthermore, these effects of MUC20 on EOC cells were also demonstrated in MUC20 knockdown cells. Conclusions. Our results suggest that MUC20 enhances aggressive behaviors of EOC cells by activating integrin beta 1 signaling and provide novel insights into the role of MUC20 in ovarian cancer metastasis. (c) 2015 Elsevier Inc. All rights reserved.